Background. Fluoroquinolone-resistant Escherichia coli are increasingly prevalent. Their clonal originspotentially critical for control efforts-remain undefined.
agents for treating multiple types of bacterial infection, including urinary tract infections (UTIs), most of which are caused by Escherichia coli [1, 2] . However, FQ resistance in E. coli is increasingly prevalent, resulting in some patients progressing to severe illness 45 or death despite receiving conventional empirical or prophylactic therapy [3, 4] . In part because of this, the authors of the 2010 Infectious Diseases Society of America guidelines recommended nitrofurantoin over FQs for empirical treatment of uncomplicated UTIs [5] . 50 In E. coli, although upregulated efflux pumps and plasmidencoded resistance mechanisms can reduce FQ susceptibility, high-level resistance typically requires 1-2 point mutations within the quinolone resistance-determining regions (QRDRs) of gyrA and parC, the chromosomal genes encoding the FQ 55 targets DNA gyrase and topoisomerase IV, respectively [6] .
Because of its chromosomal basis, such FQ resistance has arisen in diverse E. coli clonal lineages that presumably acquired the requisite QRDR mutations independently [7] [8] [9] . Despite the high clonal diversity of FQ-resistant (FQ-R) 60 E. coli, the past decade has seen the rapid emergence and global spread of a specific FQ resistance-associated clonal group, ST131, which is among ≥1000 E. coli sequence types (STs), as defined by multilocus sequence typing (MLST) [9] [10] [11] . As are most STs, ST131 is both genetically and pheno-65 typically diverse. For example, although ST131 first came to attention because of its close association with extendedspectrum β-lactamases (ESBLs), especially CTX-M-15 [12] , in many locales ST131 is more frequently ESBL-negative but FQ-R [9] , and these resistance traits are differentially distribu-70 ted among ST131's diverse pulsed-field gel electrophoresis (PFGE) types [13] . However, whether ST131's association with FQ resistance is from frequent, independent emergence of resistance in diverse ST131 strains, vs expansion of a single strain, remains unknown [8, 9, 11, [14] [15] [16] [17] . 75 Thus, sub-ST analysis of ST131 isolates is critical to understanding the ongoing emergence of FQ-R E. coli. Accordingly, we analyzed FQ resistance at the sub-ST level for over 350 archived or newly obtained ST131 isolates and over 700 non-ST131 E. coli isolates, by determining fine clonal diversity based 80 on individual gene loci and PFGE analysis. We sought thereby to define the clonal history of FQ resistance in ST131 and its impact on clinical population dynamics within E. coli generally.
METHODS

Isolates and Patients
85 The clonality of FQ resistance was analyzed among historical ST131 isolates (n = 236) and recent ST131 (n = 116) and non-ST131 (n = 737) human clinical isolates. The historical ST131 isolates were a convenience sample selected from multiple collections to represent diverse years of isolation (1967-2009), 90 FQ phenotypes, locales (201 isolates from across the United States; 35 international isolates from 10 countries on 5 continents), and sources, including humans (n = 173), food/companion animals (n = 52), and food/environment (n = 10) [13] . Center) and Minneapolis, Minnesota (Veterans Affairs Medical Center) [18] . Local institutional review boards approved the study protocol.
Sequence Analysis of Individual Loci
Isolates were assigned to an ST based on MLST allele profiles, 105 as determined by sequencing established MLST loci (http ://mlst.ucc.ie/mlst/dbs/Ecoli). Within-ST clonal variation was resolved on the basis of sequence variation in the E. coli fimbrial adhesin gene, fimH ( positions 64-552) [18] . The QRDR of gyrA (6-570) and parC (1-573) also was sequenced [16] .
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Maximum-likelihood trees were inferred for gyrA and parC using PAUP* [13] .
Pulsed-field Gel Electrophoresis Analysis
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The 352 historical and recent ST131 isolates underwent standardized XbaI pulsed-field gel electrophoresis (PFGE) analysis, with pulsotypes defined at ≥94% PFGE profile similarity to index strains for each pulsotype [13] . For dendrogram construction, a 24% subsample (n = 85) was used to allow single-130 page readability. The 85 ST131 isolates were selected randomly after deliberate inclusion of the earliest ( plus a second, as available) representative of each fimH-gyrA-parC combination. The dendrogram was inferred within BioNumerics (Applied Maths) according to the unweighted pair group method based 135 on Dice similarity coefficients.
Statistical Analysis
Fisher exact test (2-tailed) was used to test comparisons of proportions. The significance criterion was P < .05. However, none of the fimH-based lineages were confined to a single clade on the PFGE tree (Figure 1 ), reflecting certain level of phylogenetic incongruence between the 2 typing methods. The H subclones were next analyzed for associations with 160 FQ resistance and prevalence during the study period (1967-2011; Figure 2A ). During the earliest period (1967-1999), only FQ-susceptible (FQ-S) subclones were encountered, predominantly H22 and H35. FQ-R isolates appeared first during 2000-2005, associated almost exclusively with the (newly de-165 tected) H30 subclone. Thereafter, the H30 subclone continued to account for >97% of FQ-R ST131 isolates and constituted an increasing proportion of ST131 isolates overall.
RESULTS
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FQ
The FQ-R ST131 Clonal Expansion Involved Almost Exclusively a Single gyrA/parC Combination 170 Among the 352 E. coli ST131 study isolates, sequence analysis of gyrA and parC identified 7 gyrA alleles and 10 parC alleles (Tables 1 and 2 ; Figure 3 ). The gyrA alleles differed by no more than 1 single-nucleotide polymorphism (SNP), suggesting evolution by point mutation (Table 1 ; Figure 3A ). All FQ-S isolates 175 possessed either the putative ancestor allele gyrA1 or a derivative thereof containing either one silent SNP (gyrA1a) or one amino acid replacement mutation, ie, Ser-83-Leu (gyrA1A) or Asp-87-Asn (gyrA1B). In contrast, all FQ-R isolates possessed gyrA alleles that differed from gyrA1A by distinct secondary 180 replacement mutations at Asp-87: gyrA1AB (Asp-87-Asn), gyrA1AC (Asp-87-Gly), and gyrA1AD (Asp-87-Tyr). Among the 10 parC alleles, 6 closely related alleles likewise appeared to have evolved by point mutation (Table 2; Figure 3B , gray box). Most FQ-S isolates possessed the putative ancestor 185 allele, parC1, or a variant containing 1 silent SNP ( parC1a and parC1b). In contrast, most FQ-R isolates possessed parC1aAB ( parC1a plus replacement mutations Ser-80-Ile and Glu-84-Val), parC1aABC ( parC1aAB plus replacement mutation Pro-32-Ser), or parC1D ( parC1 plus replacement mutation 190 Ser-80-Arg). The 4 remaining parC alleles instead differed by multiple (≥3) silent SNPs, suggesting horizontal gene transfer. Two such alleles, parC4A and parC3A, occurred in FQ-R isolates and shared replacement mutation Ser-80-Ile. The 7 gyrA and 10 parC alleles occurred in ST131 in 18 195 combinations ( Figure 3C ). Among FQ-S isolates the gyrA1/ parC1 ancestral allele combination ( Figure 3C ) occurred in slightly more than half of isolates and in most H subclones ( Figure 2B ). In contrast, among FQ-R isolates the gyrA1AB/ parC1aAB combination predominated overwhelmingly (98% 200 of FQ-R isolates; Figure 3C ), associated almost exclusively with the H30 subclone ( Figure 2B ).
The H30 ST131 Subclone Is Associated With FQ Resistance Globally, Regardless of Source, and With CTX-M-15
Among the 236 historical ST131 isolates, the H30 ST131 sub-205 clone was closely associated with FQ resistance regardless of locale and source, and with ESBL production and bla CTX-M-15 . Specifically, among US isolates the H30 subclone accounted for 122 of 126 (97%) FQ-R isolates, vs 1 of 75 (1%) FQ-S isolates (P < .001), and among international isolates for 26 of 27 210 (96%) FQ-R isolates, vs 0 of 8 (0%) FQ-S isolates (P < .001). Similarly, among human-source isolates it accounted for 136 of 140 (97%) FQ-R isolates, vs 0 of 32 (0%) FQ-S isolates (P < .001), and among non-human-source isolates for 13 of 13 (100%) FQ-R isolates, vs 1 of 51 (2%) FQ-S isolates (P < .001).
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The 13 non-human-source FQ-R H30 subclone isolates, all with the gyrA1AB/parC1aAB combination, represented diverse animal hosts, including dogs, cats, a primate, and a dolphin (data not shown). Regarding cephalosporin resistance, the H30 subclone accounted for 92 of 108 (85%) ESBL-positive isolates, vs 57 of 220 128 (45%) ESBL-negative isolates (P < .001), and among ESBLpositive isolates for 63 of 68 (93%) bla CTX-M-15 -positive isolates, vs 29 of 40 (73%) bla CTX-M-15 -negative isolates (P < .01).
ST131's Principal FQ-R gyrA/parC Combination Is Confined to ST131
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The isolates gyrA and parC were sequenced also from selected non-ST131 recent clinical isolates, including all 78 non-ST131 FQ-R isolates, plus 63 FQ-S isolates from the same STs. To avoid false inferences of evolutionary relatedness due to repeated occurrence of the same resistance-associated replace-230 ment mutations in different lineages, phylogenetic trees were inferred for gyrA and parC based only on silent SNPs (green: Figure 4 ), after which the replacement mutations were added to the corresponding tree branches (red: Figure 4) .
In contrast to ST131's mutation-evolved gyrA and parC 235 alleles, the 4 parC alleles suspected of being horizontally transferred into ST131 ( Figure 3B ) clearly derived from non-ST131 regions of the parC tree ( Figure 4) . Moreover, horizontal transfer of gyrA and parC occurred extensively throughout the species, with most alleles appearing in multiple STs (as indi-240 cated by the diverse STs listed for certain alleles) and/or in diverse combinations (as indicated by the cross-links connecting certain gyrA alleles to multiple parC alleles, and vice versa; Figure 4 ). In contrast, ST131's signature gyrA1AB and parC1aAB alleles, and their combination (heavy cross-link), Overall, based on fimH typing (combined with MSLT), 185 total H subclones were identified among the 853 recent clinical E. coli isolates. The H30 ST131 subclone was by far the most prevalent (10.4% overall), followed only distantly by H 260 subclones from historically dominant lineages such as ST95, ST69, ST127, and ST73 ( Figure 5 ). The H30 subclone also dominated for resistance to each studied antimicrobial, for example, FQs (52% H30) and ceftriaxone (21% H30), and for multidrug resistance ( Figure 5 ).
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DISCUSSION
Here we show that, despite the repeated independent emergence of FQ resistance within E. coli, most current FQ-R E. coli clinical isolates appear to have originated about a decade ago from a single strain that emerged within ST131 as the Figure 3 . Asterisks identify the ST131 isolates' principal gyrA/parC allele combination (ie, gyrA1AB/parC1aAB). ages (ie, STs) of E. coli commonly comprise highly heterogeneous strains. For example, ST73, a major ST among extraintestinal pathogenic E. coli, also includes nonpathogenic strains Nissle1917 and ABU83972, which are used as probiotics [18, 21] . Recently, we showed that STs can be divided into 285 ecologically distinct subclones by sequencing an internal region of fimH [18] . This gene, encoding the type 1 fimbrial adhesin, is subject to more rapid evolution and horizontal gene transfer than the traditional MLST loci, which are expected to evolve neutrally [22] . Our results suggest that FQ 290 resistance, a hallmark phenotype of (clonally diverse) ST131, is associated almost exclusively with a single fimH-based subclone, H30, carrying a distinct gyrA and parC allele combination. The close relatedness of H30 isolates strongly suggests that, remarkably, the H30 subclone-and, thus, most current 295 FQ-R E. coli-arose from a single strain as recently as 1 decade ago. Notably, the single-strain origin of H30 subclone was more apparent from sequence analysis of gyrA and parC (which are widely separated on the chromosome) than from PFGE analysis, consistent with the limited phylogenetic validi-300 ty of PFGE [7] .
The finding of a predominantly single-strain origin of FQ resistance within ST131 and E. coli generally is quite surprising. Indeed, FQ resistance can potentially emerge in any E. coli strain by appropriate, analogous point mutations in the 305 QRDR of the ubiquitous housekeeping genes gyrA and parC [6, 23] . Our study confirms this and newly documents that FQ resistance-conferring gyrA and parC alleles also exhibit extensive horizontal mobility, thereby disseminating FQ resistance rapidly among different E. coli STs. Even within ST131, FQ 310 resistance-conferring parC alleles have entered multiple times via horizontal transfer, as illustrated in Figure 4 . Nevertheless, a single allelic combination-gyrA1AB/parC1aAB -has achieved predominance within ST131 and, consequently, the species overall. 315 The observed tight linkage between a single gyrA/parC combination and the H30 ST131 subclone conceivably could be due to this lineage's superior FQ resistance, commensal fitness, and/or pathogenicity, compared with other E. coli. Greater FQ resistance, if present, could represent an effect of the distinctive 320 Glu-84-Val parC replacement mutation, which occurs in ST131's hallmark parC1aAB allele along with the widespread Ser-80-Leu mutation. Further, although plasmid-borne FQ resistance and up-regulated efflux pumps are uncommon in ST131 [15, 16] , other traits of the H30 subclone conceivably 325 could augment its resistance, for example, by blocking FQ entry or increasing intracellular FQ inactivation [6] . Comparative assessment of FQ minimum inhibitory concentrations among FQ-R ST131 vs non-ST131 E. coli isolates is needed. Regarding commensalism, resistance-conferring mutations 330 in housekeeping genes may decrease overall bacterial fitness when antimicrobial selective pressure is absent, unless compensatory mutations have coevolved with the resistance [24] , possibly resulting in a competitive advantage in the commensal niche over other E. coli. In this regard, the H30 subclone's 335 broad host range may also promote its dissemination through the population, both within and among locales [25] . Finally, the H30 subclone might be more fit in the pathogenic niche, and this, in combination with FQ resistance, could underlie its rapid rise to clinical dominance over other 340 E. coli. The current dominance of the H30 subclone clearly surpasses such common lineages as ST69 ("clonal group A"; associated with trimethoprim-sulfamethoxazole resistance [7] ) and classic extraintestinal pathogenic lineages ST95, ST73, and ST127. We are currently exploring the successful features of 345 the H30 subclone through comparative genomics and molecular epidemiological surveys. Recognition of the H30 ST131 subclone has direct clinical implications. First, rapid diagnostics that detect this singlestrain lineage, analogous to those currently used for rapid de-350 tection of methicillin-resistant Staphylococcus aureus, could allow better targeted selection of empirical antimicrobial therapy for patients in whom FQ-R E. coli are of concern [5] . Second, identification of relevant reservoirs and transmission pathways of the H30 subclone, and development of effective 355 interventions against them, could limit its spread [3] . Third, development of an effective vaccine directed toward H30 subclone-associated antigens (eg, surface-exposed virulence factors, and/or the O25 somatic antigen or H4 flagellar antigen) could help protect at-risk hosts [11, 26] . Thus, 360 focused attention to the highly successful H30 ST131 subclone can potentially lead to substantially improved prevention and management of FQ-R E. coli infections.
Study limitations included the exclusive focus on gyrA/ parC-mediated FQ resistance, the use of convenience sample 365 historical isolates (albeit broadly distributed by year, locale, and source/host), and the current isolates' geographical restriction to 2 US cities (albeit from 5 separate institutions serving distinct patient populations). Strengths include the large and diverse study population for comparison of ST131 and non-370 ST131 E. coli, the use of multiple advanced molecular modalities to define sub-ST131 clonal structure, the clonal phylogenetic analysis of mutations in gyrA and parC, and the clonal assessment of resistance. In summary, we provide evidence suggesting that the major 375 source of the current FQ resistance epidemic in E. coli is the rapid clonal expansion of a single strain within ST131, which over the past decade has become the most successful lineage of extraintestinal E. coli overall, particularly of multidrugresistant E. coli. Although confirmation of these findings in other 380 locales and host populations is needed, this discovery provides a novel perspective on the E. coli antimicrobial resistance epidemic, with profound implications and exciting opportunities. . gyrA and parC phylogenetic trees for ST131 isolates and diverse fluoroquinolone (FQ)-resistant non-ST131 Escherichia coli isolates. Trees were built based on silent variation only (green branches); FQ-resistance-determining amino acid replacement changes were then added manually (red branches and labels). STc: ST complexes (groups of closely related STs) within which the indicated alleles are found. Diagonal lines indicate gyrA/parC combinations (dashed green, in FQ-susceptible ST131 isolates; dashed red, in FQ-R ST131 isolates; solid black, in FQ-R non-ST131 isolates). Blue/boldface labels: the 17 alleles found in ST131, named according to the nomenclature used in Figure 3 . "ST131 (historic)" marks ST131-associated alleles found only in historic ST131 isolates. 
